In this supplement:Colloidal Oatmeal Part I: History, Basic Science, Mechanism of Action, and Clinical Efficacy in the Treatment of Atopic DermatitisColloidal oatmeal has a long-standing history in the treatment of…
Read More
INTRODUCTIONHistory of Oatmeal Oatmeal has a longstanding and rich history pertaining to its dermatologic use. The first documentation of oatmeal for skin health dates back as early as 2000 BC…
Read More
INTRODUCTIONAtopic Dermatitis in Skin of ColorIn Part I, we examined the ways in which colloidal oatmeal can be beneficial in the treatment of AD. Colloidal oatmeal has also been found…
Read More
INTRODUCTIONAtopic dermatitis (AD) is a chronic, inflammatory skin disease affecting 2%–7% of adults globally.1-3 While itch has been reported as the hallmark and most burdensome symptom of AD,4 other symptoms…
Read More
INTRODUCTIONHistory of Transient Acantholytic Dermatosis (Grover Disease) Transient acantholytic dermatosis, or Grover disease, is a rare acantholytic skin disorder that was first described by Dr. Ralph Weir Grover.1 Over the…
Read More
INTRODUCTIONIncobotulinumtoxinA (INCO; Xeomin®, Bocouture®; Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany) is the only commercially available botulinum toxin A (BoNT/A) preparation free from complexing proteins.1 INCO is currently approved in…
Read More
To the Editor, We read, with interest, Maarouf et al’s study, Skin cancer epidemiology and sun protection behaviors among Native Americans (J Drugs Dermatol. 2019; 18(5):420- 423), which provided insight…
Read More
INTRODUCTIONSkin of color patients with psoriasis face unique challenges related to disease characteristics and treatment. Distribution and severity of psoriasis may be greater in patients with skin of color.1,2 Dyspigmentation—including…
Read More
INTRODUCTIONLymphomatoid papulosis (LyP) is a chronic skin condition, characterized by recurrent eruptions of papules and nodules with or without central necrosis that spontaneously resolve. This condition was originally described by…
Read More
Tumor necrosis factor-α inhibitors (TNFIs) have significantly improved the quality of life for patients with psoriasis and psoriatic arthritis. Despite their beneficial effects, TNFIs have been reported to cause paradoxical…
Read More
INTRODUCTIONCOVID-19 is caused by a coronavirus first identified after an outbreak of atypical pneumonia in Wuhan, China in December 2019. On January 7, 2020 the World Health Organization (WHO) officially…
Read More
INTRODUCTIONRosacea is a chronic, multifactorial condition associated with various phenotypes affecting the centrofacial skin.1 The primary diagnostic phenotypes for rosacea, as defined by the National Rosacea Society, include fixed centrofacial…
Read More
